Quicksilver Biosciences is developing a rapid, point-of-care diagnostic tool that can identify a vast array of analytes with unprecedented single-molecule precision.
Year Founded: 2018
Key Executives: Erik Young, CEO
Location: New York, NY
Website: https://www.quicksilverbiosciences.com/
Company Status: Private
Year Invested: 2018
Investment Status: Current
Board Member: Josh Palmer